Two Models of Legalization of Psychedelic Substances: Reasons for Concern.
作者信息
Smith William R, Appelbaum Paul S
机构信息
Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Scattergood Program for Applied Ethics of Behavioral Health Care, Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
出版信息
JAMA. 2021 Aug 24;326(8):697-698. doi: 10.1001/jama.2021.12481.
Abstract
摘要
相似文献
1
Two Models of Legalization of Psychedelic Substances: Reasons for Concern.
JAMA. 2021 Aug 24;326(8):697-698. doi: 10.1001/jama.2021.12481.
2
State Cannabis and Psychedelic Legislation and Microdosing Interest in the US.
JAMA Health Forum. 2024 Jun 7;5(6):e241653. doi: 10.1001/jamahealthforum.2024.1653.
3
Treatment of alcoholism using psychedelic drugs: a review of the program of research.
J Psychoactive Drugs. 1998 Oct-Dec;30(4):381-418. doi: 10.1080/02791072.1998.10399714.
4
A Public-Health-Based Vision for the Management and Regulation of Psychedelics.
J Psychoactive Drugs. 2016 Sep-Oct;48(4):243-52. doi: 10.1080/02791072.2016.1202459. Epub 2016 Jul 18.
5
Impact of state-level cannabis legalization on poly use of alcohol and cannabis in the United States, 2004-2017.
Drug Alcohol Depend. 2021 Jan 1;218:108364. doi: 10.1016/j.drugalcdep.2020.108364. Epub 2020 Oct 18.
6
Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey.
J Psychoactive Drugs. 2022 Jul-Aug;54(3):269-277. doi: 10.1080/02791072.2021.1957183. Epub 2021 Aug 19.
7
Psychedelic Drug Legislative Reform and Legalization in the US.
JAMA Psychiatry. 2023 Jan 1;80(1):77-83. doi: 10.1001/jamapsychiatry.2022.4101.
8
Admissions to substance use treatment facilities for cannabis use disorder, 2000-2017: Does legalization matter?
Am J Addict. 2022 Sep;31(5):423-432. doi: 10.1111/ajad.13286. Epub 2022 Apr 2.
9
Direct democracy and the adoption of recreational marijuana legalization in the United States, 2012-2019.
Int J Drug Policy. 2022 Apr;102:103583. doi: 10.1016/j.drugpo.2022.103583. Epub 2022 Feb 4.
10
Trends in cannabis use among adults with children in the home in the United States, 2004-2017: impact of state-level legalization for recreational and medical use.
Addiction. 2021 Oct;116(10):2770-2778. doi: 10.1111/add.15472. Epub 2021 Mar 26.
引用本文的文献
1
Ethical Issues and Recommendations in Psychedelic Research and Practice: A Scoping Review.
J Bioeth Inq. 2025 Aug 7. doi: 10.1007/s11673-025-10454-3.
2
Geographical Differences in Self-Reported Past 12-Month Drug Use: Results from the NDEWS Rapid Street Reporting, 2021-2023.
Subst Use Misuse. 2025;60(11):1678-1689. doi: 10.1080/10826084.2025.2511242. Epub 2025 Jun 5.
3
Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper.
Eur Psychiatry. 2025 Jan 10;68(1):e3. doi: 10.1192/j.eurpsy.2024.1806.
4
Psychedelics in PERIL: The Commercial Determinants of Health, Financial Entanglements and Population Health Ethics.
Public Health Ethics. 2024 Mar 1;17(1-2):24-39. doi: 10.1093/phe/phae002. eCollection 2024 Apr-Jul.
5
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.
CNS Drugs. 2024 Oct;38(10):771-789. doi: 10.1007/s40263-024-01101-3. Epub 2024 Jul 20.
6
Long-term benefits to psychological health and well-being after ceremonial use of Ayahuasca in Middle Eastern and North African immigrants and refugees.
Front Psychiatry. 2024 Apr 10;15:1279887. doi: 10.3389/fpsyt.2024.1279887. eCollection 2024.
7
A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia.
Aust N Z J Psychiatry. 2024 Jul;58(7):571-590. doi: 10.1177/00048674241240597. Epub 2024 Apr 16.
8
A Perspective on Psychedelics as Treatments for Addictions.
J Stud Alcohol Drugs. 2024 Sep;85(5):583-588. doi: 10.15288/jsad.23-00032. Epub 2024 Mar 22.
9
National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022.
Drug Alcohol Depend. 2024 May 1;258:111086. doi: 10.1016/j.drugalcdep.2024.111086. Epub 2024 Feb 6.
10
The safety of supported psilocybin use in Oregon.
Nat Med. 2024 Jan;30(1):17-18. doi: 10.1038/s41591-023-02727-4.
本文引用的文献
1
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Nat Med. 2021 Jun;27(6):1025-1033. doi: 10.1038/s41591-021-01336-3. Epub 2021 May 10.
2
Trends over time in adult cannabis use: A review of recent findings.
Curr Opin Psychol. 2021 Apr;38:80-85. doi: 10.1016/j.copsyc.2021.03.005. Epub 2021 Mar 20.
3
Trial of Psilocybin versus Escitalopram for Depression.
N Engl J Med. 2021 Apr 15;384(15):1402-1411. doi: 10.1056/NEJMoa2032994.
4
MDMA-related presentations to the emergency departments of the European Drug Emergencies Network plus (Euro-DEN Plus) over the four-year period 2014-2017.
Clin Toxicol (Phila). 2021 Feb;59(2):131-137. doi: 10.1080/15563650.2020.1784914. Epub 2020 Jul 17.
5
Psychedelics and Psychedelic-Assisted Psychotherapy.
Am J Psychiatry. 2020 May 1;177(5):391-410. doi: 10.1176/appi.ajp.2019.19010035. Epub 2020 Feb 26.
6
Psychotic disorders hospitalizations associated with cannabis abuse or dependence: A nationwide big data analysis.
Int J Methods Psychiatr Res. 2020 Mar;29(1):e1813. doi: 10.1002/mpr.1813. Epub 2019 Dec 5.
7
Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016.
JAMA Psychiatry. 2020 Feb 1;77(2):165-171. doi: 10.1001/jamapsychiatry.2019.3254.
8
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.
J Psychopharmacol. 2016 Dec;30(12):1268-1278. doi: 10.1177/0269881116662634. Epub 2016 Aug 30.
9
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.
J Psychopharmacol. 2015 Mar;29(3):280-8. doi: 10.1177/0269881114565653. Epub 2015 Jan 13.
10
Psychedelics and mental health: a population study.
PLoS One. 2013 Aug 19;8(8):e63972. doi: 10.1371/journal.pone.0063972. eCollection 2013.
Zotero 插件